We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
+13.64%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$125M
AUM Growth
+$16.3M
(+15%)
Cap. Flow
+$8.43M
Cap. Flow
% of AUM
6.73%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
71
New
8
Increased
24
Reduced
9
Closed
7
Top Buys
| 1 |
Rigel Pharmaceuticals
RIGL
|
+$3.41M |
| 2 |
Talos Energy
TALO
|
+$1.71M |
| 3 |
Copa Holdings
CPA
|
+$1.58M |
| 4 |
Park Hotels & Resorts
PK
|
+$1.46M |
| 5 |
Freeport-McMoran
FCX
|
+$1.35M |
Top Sells
| 1 |
Baidu
BIDU
|
+$2.59M |
| 2 |
Alibaba
BABA
|
+$2.16M |
| 3 |
Newmark Group
NMRK
|
+$1.3M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$1.03M |
| 5 |
Hasbro
HAS
|
+$878K |
Sector Composition
| 1 | Healthcare | 39.93% |
| 2 | Materials | 10.94% |
| 3 | Technology | 9.96% |
| 4 | Industrials | 9.07% |
| 5 | Financials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
CVS Health
CVS
$136B
| $2.2M | 1.76% |
35,000
+5,000
| +17% | +$292K |
|
|
27
Park Hotels & Resorts
PK
$2.94B
| $2.12M | 1.69% |
150,000
+100,000
| +200% | +$1.46M |
|
28
Coherus Oncology
CHRS
$214M
| $2.08M | 1.66% |
2,000,000
+900,000
| +82% | +$1.23M |
|
29
Organon & Co
OGN
$3.54B
| $1.91M | 1.53% |
100,000
-25,000
| -20% | -$518K |
|
30
First Financial Corp
THFF
$929M
| $1.86M | 1.49% |
42,500
+2,500
| +6% | +$106K |
|
|
WBA
31
DELISTED
Walgreens Boots Alliance
WBA
| $1.79M | 1.43% |
200,000
+50,000
| +33% | +$514K |
|
32
Pfizer
PFE
$143B
| $1.74M | 1.39% |
60,000
+10,000
| +20% | +$292K |
|
|
33
Copa Holdings
CPA
$5.89B
| $1.64M | 1.31% |
+17,500
| New | +$1.58M |
|
34
Cohu
COHU
$2.43B
| $1.54M | 1.23% |
60,000
+30,000
| +100% | +$841K |
|
|
35
Freeport-McMoran
FCX
$84.2B
| $1.5M | 1.2% |
+30,000
| New | +$1.35M |
|
36
Xoma
XOMA
| $1.46M | 1.16% |
55,000
| – | – |
|
37
Warner Bros
WBD
$68.4B
| $1.44M | 1.15% |
175,000
-25,000
| -13% | -$195K |
|
|
SVC
38
Service Properties Trust
SVC
$1.13B
| $1.37M | 1.09% |
60,000
| – | – |
|
39
Herc Holdings
HRI
$5.11B
| $1.28M | 1.02% |
+8,000
| New | +$1.13M |
|
40
AMCON Distributing
DIT
$66.9M
| $1.21M | 0.96% |
12,500
+200
| +2% | +$19.2K |
|
41
Cytosorbents Corp
CTSO
$23.2M
| $1.2M | 0.96% |
800,000
-50,000
| -6% | -$54.8K |
|
42
Acadia Pharmaceuticals
ACAD
$4.39B
| $1.08M | 0.86% |
70,000
+30,000
| +75% | +$500K |
|
43
Perrigo
PRGO
$1.54B
| $1.05M | 0.84% |
+40,000
| New | +$1.1M |
|
44
Pan American Silver
PAAS
$17.7B
| $1.04M | 0.83% |
50,000
-25,000
| -33% | -$527K |
|
45
Heron Therapeutics
HRTX
$90.1M
| $995K | 0.79% |
500,000
+200,000
| +67% | +$478K |
|
46
Nektar Therapeutics
NKTR
$2.27B
| $975K | 0.78% |
50,000
| – | – |
|
47
Battalion Oil
BATL
$34.6M
| $934K | 0.75% |
140,000
| – | – |
|
48
Coya Therapeutics
COYA
$108M
| $929K | 0.74% |
144,059
+44,059
| +44% | +$278K |
|
49
Atea Pharmaceuticals
AVIR
$377M
| $905K | 0.72% |
270,000
| – | – |
|
50
Newell Brands
NWL
$2.31B
| $768K | 0.61% |
100,000
-75,000
| -43% | -$537K |
|
Similar funds
AA
CC
DG
ACM
WAG
YMRC
IW
BCWM